Literature DB >> 7389203

Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome.

G Starkebaum, J W Singer, W P Arend.   

Abstract

The objective of these studies was to assess the relative role of humoral or cellular immune mechanisms in the neutropenia of Feltry's syndrome. The amounts of neutrophil-bound IgG were measured by a sensitive antiglobulin inhibition assay. These values were increased in eight out of seventeen patients with Felty's syndrome over the highest values seen with seventeen patients with rheumatoid arthritis without leukopenia or twenty-six normal individuals. The levels of serum IgG neutrophil-binding activity from thirteen out of twenty-one patients with Felty's syndrome were greater than the highest values seen with normal sera compared to six out of thirty sera from patients with rheumatoid arthritis alone. A strong correlation was observed between the levels of direct neutrophil-bound IgG and the serum IgG neutrophil-binding activity for the seventeen patients with Felty's syndrome. Inhibition of normal marrow granulocyte colony growth greater than 40% was seen with the peripheral blood mononuclear leucocytes from five out of eleven patients with Feltry's syndrome. All five patients had normal levels of neutrophil bound IgG and normal to moderately increased levels of serum IgG neutrophil binding activity. In contrast, of the six patients whose mononuclear leucocytes did not inhibit granulocyte colony growth, three had markedly elevated levels of neutrophil-bound IgG and four had elevated levels of serum IgG neutrophil binding activity. These results suggest that humoral and cellular immune mechanisms of neutropenia may be present in different subsets of patients with Felty's syndrome.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389203      PMCID: PMC1538071     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  White-cell antibodies and the aetiology of Felty's syndrome.

Authors:  F D Rosenthal; J M Beeley; K Gelsthorpe; R W Doughty
Journal:  Q J Med       Date:  1974-04

2.  The mechanism of neutropenia in Felty's syndrome.

Authors:  P C Vincent; J A Levi; A Macqueen
Journal:  Br J Haematol       Date:  1974-07       Impact factor: 6.998

3.  Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum.

Authors:  M Mannik; D E Stage
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

4.  Granulopoiesis in neutropenic disorders.

Authors:  P L Greenberg; S L Schrier
Journal:  Blood       Date:  1973-06       Impact factor: 22.113

5.  Marrow granulocyte reserves in the rheumatic diseases.

Authors:  H R Kimball; S M Wolff; N Talal; P H Plotz; J L Decker
Journal:  Arthritis Rheum       Date:  1973 May-Jun

6.  Leukokinetic studies. XIV. Blood neutrophil kinetics in chronic, steady-state neutropenia.

Authors:  C R Bishop; G Rothstein; H E Ashenbrucker; J W Athens
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

7.  An improved method for performing neutrophil survival studies.

Authors:  A S Deinard; A R Page
Journal:  Blood       Date:  1970-07       Impact factor: 22.113

8.  Granulopoietic activity in Felty's syndrome.

Authors:  R Gupta; W A Robinson; D Albrecht
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

9.  An analysis of the immunological specificity of antiserum against human IgG F(ab)2.

Authors:  R S Smith; R L Longmire; R T Reid; R S Farr
Journal:  Immunochemistry       Date:  1970-07

10.  Effects of heterologous antineutrophil serum in guinea pigs. Hematologic and ultrastructural observations.

Authors:  D M Simpson; R Ross
Journal:  Am J Pathol       Date:  1971-10       Impact factor: 4.307

View more
  13 in total

1.  Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.

Authors:  Violeta Romero; Justyna Fert-Bober; Peter A Nigrovic; Erika Darrah; Uzma J Haque; David M Lee; Jennifer van Eyk; Antony Rosen; Felipe Andrade
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

2.  Depressed superoxide radical generation by neutrophils from patients with rheumatoid arthritis and neutropenia: correlation with neutrophil reactive IgG.

Authors:  P Davis; C Johnston; J Bertouch; G Starkebaum
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

3.  Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.

Authors:  M J Ahern; P J Roberts-Thomson; J Bradley; C Story; P Seshadri
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

4.  Chlorthalidone-associated neutropenia.

Authors:  S T Writer; D L Stevens; G Starkebaum
Journal:  West J Med       Date:  1982-01

5.  Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome.

Authors:  H J Ditzel; Y Masaki; H Nielsen; L Farnaes; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  GM-CSF and G-CSF in Felty's syndrome.

Authors:  D R Wagner; C Combe; U Gresser
Journal:  Clin Investig       Date:  1993-02

8.  Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.

Authors:  B Hellmich; A Ciaglo; H Schatz; G Coakley
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

9.  Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia.

Authors:  Marcin Wojciech Wlodarski; Zachary Nearman; Ying Jiang; Alan Lichtin; Jaroslaw Pawel Maciejewski
Journal:  Exp Hematol       Date:  2008-03       Impact factor: 3.084

10.  Immune complexes and the pathogenesis of neutropenia in Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E de Vries; J H van Krieken; A Cats
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.